Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100000 participants
INTERVENTIONAL
2012-03-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is hypothesised that as a result of the scale and multi-pronged nature of the campaign, reductions of between 10% and 20% in child mortality will be achieved.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Mass Media Family Planning Campaign on the Uptake of Contraceptive Methods in Burkina Faso
NCT02714686
Trial of Proactive Community Case Management to Reduce Child Mortality
NCT02694055
Ghana Newborn Home Visits Neonatal Mortality Trial
NCT00623337
Community-Based Interventions for Infant Health in Nepal
NCT00656591
Child Protective Outcomes Among Ultra-poor Families in Burkina Faso
NCT02415933
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data collection includes household surveys in all 14 clusters at three "key" times:
* At baseline: Before the implementation of the intervention, between December 2011 and February 2012 to measure the current level of child mortality and evaluate current knowledge and behaviours of relevance to child health.
* At midline: Fifteen months after implementation of the intervention to evaluate the coverage of the intervention (in the intervention clusters) and, in each cluster, knowledge and behaviours.
* At endline: Two and a half years after implementation of the intervention to evaluate intervention coverage (in the intervention clusters), knowledge and behaviours and child mortality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention
seven clusters where radio media campaign will be broadcast.
Local radio campaign to reduce under-five child mortality
The media campaign is designed by Development Media International. It includes short "spots" and long format programs broadcast by rural community radios. Major topics to be addressed include: diarrhoea, water and sanitation, acute respiratory infections, fever/malaria, antenatal consultations, delivery in health facilities, breastfeeding, and child nutrition. The intervention is planned to start in March 2012 after completion of fieldwork for the baseline survey and will continue for 2.5 years.
control
Seven clusters where radio media campaign won't be broadcast.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Local radio campaign to reduce under-five child mortality
The media campaign is designed by Development Media International. It includes short "spots" and long format programs broadcast by rural community radios. Major topics to be addressed include: diarrhoea, water and sanitation, acute respiratory infections, fever/malaria, antenatal consultations, delivery in health facilities, breastfeeding, and child nutrition. The intervention is planned to start in March 2012 after completion of fieldwork for the baseline survey and will continue for 2.5 years.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Development Media International
OTHER
Centre Muraz
OTHER
Wellcome Trust
OTHER
Planet Wheeler Foundation
UNKNOWN
London School of Hygiene and Tropical Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simon N Cousens, MA
Role: PRINCIPAL_INVESTIGATOR
London School of Hygiene and Tropical Medicine
Nicolas Meda, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Muraz
Sophie Sarrassat, PhD
Role: STUDY_DIRECTOR
London School of Hygienne and Tropical Medicine
Moctar Ouedraogo, MsD
Role: STUDY_DIRECTOR
Centre MURAZ / AfricSanté, Burkina Faso
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Muraz
Bobo-Dioulasso, , Burkina Faso
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kasteng F, Murray J, Cousens S, Sarrassat S, Steel J, Meda N, Ouedraogo M, Head R, Borghi J. Cost-effectiveness and economies of scale of a mass radio campaign to promote household life-saving practices in Burkina Faso. BMJ Glob Health. 2018 Jul 16;3(4):e000809. doi: 10.1136/bmjgh-2018-000809. eCollection 2018.
Sarrassat S, Meda N, Badolo H, Ouedraogo M, Some H, Bambara R, Murray J, Remes P, Lavoie M, Cousens S, Head R. Effect of a mass radio campaign on family behaviours and child survival in Burkina Faso: a repeated cross-sectional, cluster-randomised trial. Lancet Glob Health. 2018 Mar;6(3):e330-e341. doi: 10.1016/S2214-109X(18)30004-4.
Head R, Murray J, Sarrassat S, Snell W, Meda N, Ouedraogo M, Deboise L, Cousens S. Can mass media interventions reduce child mortality? Lancet. 2015 Jul 4;386(9988):97-100. doi: 10.1016/S0140-6736(14)61649-4. Epub 2015 Feb 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6028
Identifier Type: OTHER
Identifier Source: secondary_id
2011-9-56
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.